X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

JOURNAL OF EXPERIMENTAL MEDICINE

期刊標題檢索 J EXP MED 最新評論: I would like to ask how long the Initial Manuscript Assessment Start... (2026-04-06)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[JOURNAL OF EXPERIMENTAL MEDICINE]您好,您是該頁面的第 107979 位訪客。

期刊簡介
期刊名稱JOURNAL OF EXPERIMENTAL MEDICINE JOURNAL OF EXPERIMENTAL MEDICINE
LetPub Score
9.2
50 ratings
Rate

Reputation
10.0

Influence
9.0

Speed
7.1

期刊簡稱J EXP MED
ISSN0022-1007
E-ISSN1540-9538
h-index411
CiteScore
CiteScoreSJRSNIPCiteScore Rank
22.105.8341.993
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Immunology and Allergy
Q111 / 231
Category: Medicine
Subcategory: Immunology
Q112 / 240

自引率 (2023-2024)1.60%自引率趨勢
掲載範囲
Since its inception in 1896, the goal of Journal of Experimental Medicine (JEM) has been to publish outstanding and enduring studies in medical biology. At a time when many leading publishing groups are establishing topic-specific journals, we believe it is critical to complement that approach by offering a distinguished venue for publication of studies that integrate disciplines within the field of pathogenesis.
官方網站http://jem.rupress.org/
在線稿件提交http://jem.rupress.org/site/misc/submit.xhtml
開放訪問No
出版商Rockefeller University Press
主題領域医学
出版國/地區UNITED STATES
發行頻率月2回刊行
創刊年1896
每年文章數148每年文章數趨勢
黃金OA百分比54.18%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
IMMUNOLOGYSCIEQ112/183
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ115/195
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0022-1007%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Ordinary, 3-8 Week(s)
競爭力 *來自作者的數據: Very difficult
參考鏈接
相關期刊 【JOURNAL OF EXPERIMENTAL MEDICINE】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 84.70
    NATURE IMMUNOLOGYH-index: 344

    CiteScore: 38.20
    Annual Review of ImmunologyH-index: 279

    CiteScore: 55.50
    ImmunityH-index: 355

    CiteScore: 40.80
    Cellular & Molecular ImmunologyH-index: 64

    CiteScore: 36.20
    TRENDS IN IMMUNOLOGYH-index: 209

    CiteScore: 21.20
    AUTOIMMUNITY REVIEWSH-index: 103

    CiteScore: 16.80
    BRAIN BEHAVIOR AND IMMUNITYH-index: 127

    CiteScore: 15.20
    Mucosal ImmunologyH-index: 82

    CiteScore: 16.50
    JOURNAL OF AUTOIMMUNITYH-index: 101

    CiteScore: 13.60
    學科內最受檢索的期刊 頁面查看次數
    International Immunopharmacology517191
    JOURNAL OF IMMUNOLOGY161263
    MOLECULAR IMMUNOLOGY116204
    IMMUNOLOGY113467
    Immunity112825
    Cellular & Molecular Immunology112747
    MEDIATORS OF INFLAMMATION111970
    MICROBIAL PATHOGENESIS109382
    Vaccine109313
    INFLAMMATION102677
  •  

    JOURNAL OF EXPERIMENTAL MEDICINE JOURNAL OF EXPERIMENTAL MEDICINE
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [JOURNAL OF EXPERIMENTAL MEDICINE] 的評論撰寫評論
作者: 耶耶耶accept


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-04-06 13:02:51 評論於
I would like to ask how long the Initial Manuscript Assessment Started for this magazine will last. It has been in this status for 13 days. Will rejection emails be sent to the authors, but the status on the website remains as Initial Manuscript Assessment Started?
(0) 讚! | 耶耶耶accept

作者: LS119


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2026-03-29 22:05:04 評論於
Cardiovascular direction, submitted on 3.8, in the hands of the editor on 3.9. It will be reviewed two weeks later by the editor. This manuscript has been rejected after external review by CDD and Metabolism-Clinical and Experimental journals. It is now submitted to JEM after revisions based on feedback. Good luck!
(0) 讚! | LS119

作者: Javen.Wu


領域: 医学
審稿時間: 0.0 month(s)
結果: 拒稿


撰寫評論

2025-11-26 21:56:34 評論於
The submission has been desk rejected. The chances of acceptance for non-immune-related topics are low.
(0) 讚! | Javen.Wu

作者: lz


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-11-24 12:35:39 評論於
I am not immune, so I decided to give it a try to see if I will be rejected by the table. I see that there are also a small number of non-immune people in their article.
(0) 讚! | lz

作者: Javen-Dr.Wu


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-11-24 08:42:51 評論於
Hey guys, does this magazine only accept articles on immunology?
(0) 讚! | Javen-Dr.Wu

作者: King Julian


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-17 19:05:23 評論於
Boss, could you please provide the complete timeline for me to review? Thank you.
(0) 讚! | King Julian

作者: 破戒曼珍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-29 21:54:34 評論於
Review Speed: 1.0 | Submission Acceptance Rate: 25.0 
Emphasized Research Area: Immunology 
Experience Sharing: Articles on immunology are recommended
(0) 讚! | 破戒曼珍

作者: 平原英豪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-20 22:05:46 評論於
What magazine is G & D?
(0) 讚! | 平原英豪

作者: 梦晨小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-11 08:28:50 評論於
Hello, may I ask how long it took for you to reply?
(0) 讚! | 梦晨小公主

作者: 香雪大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-10 12:12:23 評論於
It's really not easy
(0) 讚! | 香雪大叔

作者: 无相秀菊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-04 16:05:56 評論於
Hello, may I ask how long is the preliminary review process expected to take?
(0) 讚! | 无相秀菊

作者: 香雪大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-23 19:19:13 評論於
It's not easy
(0) 讚! | 香雪大叔

作者: 慧俊小仙女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-20 13:23:34 評論於
Not very positive, it's tragic
(0) 讚! | 慧俊小仙女

作者: 辉夜一莹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-06 19:31:07 評論於
JEM, EMBO J, JCI, G&D are all my dream journals, and I want them all!
(0) 讚! | 辉夜一莹

作者: 长安元绿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-16 22:00:21 評論於
It's been 12 days since submission, and the status is still "Initial Manuscript Assessment Started." Should I send an email to inquire about it?
(0) 讚! | 长安元绿

作者: 长安元绿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-16 22:00:13 評論於
How about it? Have the opinions come back? How many reviewers? Are the opinions positive?
(0) 讚! | 长安元绿

作者: 语萍酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-16 22:35:29 評論於
Review speed: 1.0 | Submission acceptance rate: 25.0 Emphasis on research direction: Immunology Experience sharing: Submitted in January, reviewed by two reviewers, both opinions were relatively positive. Spent 3 months doing additional experiments, then accepted in February, and officially online a month and a half later. Original Western Blot data needs to be provided
(0) 讚! | 语萍酱大魔王

作者: 慧俊小仙女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-15 21:39:50 評論於
Sure
(0) 讚! | 慧俊小仙女

作者: 慧俊小仙女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-06 13:16:22 評論於
Submission acceptance rate: 50.0
Preferred research direction: Immunology
Sharing of immunological experiences: This is the time to wait for revision comments. Under External Review. 2022-02-22 Initial Manuscript Assessment Started. Initial QC Complete. 2022-02-10 Initial QC Started. 2022-02-09 Author Approved Converted Files. 2022-02-09 Preliminary Manuscript Data Submitted
(0) 讚! | 慧俊小仙女

作者: 静心经义


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-01-07 12:11:13 評論於
Will I receive an email notification for the review meeting?
(0) 讚! | 静心经义

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 17:23:56 評論於
ORCID is the Researcher and Contributor ID, an open nonprofit organization. The ORCID ID is a unique and persistent academic identity for contributors, allowing authors to be distinguished from other researchers and to document all related research activities
(0) 讚! | 维尔娜菲茨杰拉德

作者: Oswald Edie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 20:16:56 評論於
What is ORCID ID? How to register?
(0) 讚! | Oswald Edie

作者: 桃花欣嘉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-16 19:03:07 評論於
Review Speed: 1.0
Focus of Study: Immunology
Experience Sharing: The reviewers are all immunology experts, very friendly, and ask questions quite professionally. The manuscript underwent major revisions on 3 figures, with the following timeline:
Preliminary Manuscript Data Submitted 2021-01-02 22:40:02
Under External Review 2021-01-14 17:08:05
Decision Sent to Author 2021-02-16 16:07:39
Revision Received 2021-05-05 22:26:29
Decision Sent to Author 2021-06-08 16:45:18
Manuscript Sent to Production 2021-06-17 16:08:32
(0) 讚! | 桃花欣嘉

作者: 斯羽酱吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-06 19:15:49 評論於
May I ask how many reviewers are there? Thank you very much
(0) 讚! | 斯羽酱吖

作者: 斯羽酱吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-05-06 17:48:12 評論於
Congratulations! How many reviewers were there at that time?
(0) 讚! | 斯羽酱吖

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [JOURNAL OF EXPERIMENTAL MEDICINE] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*